October 15 (SeeNews) - Sandoz Biopharmaceuticals, a division of the Novartis group, has opened a new laboratory for cellular and molecular biology at its development center in Slovenia's Menges which should help broaden patient access to advanced biological medicines, Slovenian Sandoz-owned pharmaceutical company LEK said.